Rozenman Mary M. 4
4 · Aimmune Therapeutics, Inc. · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Rozenman Mary M.
See Remarks
Transactions
- Award
Common Stock, $0.0001 par value
2019-02-22+7,500→ 14,504 total - Award
Stock Option (right to buy)
2019-02-22+45,000→ 45,000 totalExercise: $23.72Exp: 2029-02-22→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 6,875 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]The shares subject to the option will vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 22, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.